Fosun International LTD Acadia Pharmaceuticals Inc Transaction History

Fosun International LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$23.32 - $28.12 $1.38 Million - $1.66 Million	-59,000 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$16.17 - $27.38 $1.88 Million - $3.18 Million	-116,000 Reduced 66.29%	59,000 $1.57 Million
Q4 2018 Jan 31, 2019	SELL	$14.32 - $22.92 $486,880 - $779,280	-34,000 Reduced 16.27%	175,000 $2.7 Million
Q3 2018 Nov 09, 2018	BUY	$13.03 - $21.81 $2.72 Million - $4.56 Million	209,000 New	209,000 $4.56 Million

299

158M

1.88M

688K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.